Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCheckit Regulatory News (CKT)

Share Price Information for Checkit (CKT)

Share Price is delayed by 15 minutes
Get Live Data
21.50    0.00 (0.00%)
Bid:
21.00
Ask:
22.00
Spread: 1.00 (4.762%)
Market Cap: £23.22m
CKT Live PriceLast checked at - London Stock Exchange

Intraday Checkit Share Chart

Trading Statement

9 Aug 2018 07:00

RNS Number : 2642X
Elektron Technology PLC
09 August 2018
 

Elektron Technology plc

("Elektron" or the "Company")

 

Trading Update

 

 

Elektron Technology Plc, the global technology group, is pleased to provide an update on trading for the six months ended 31 July 2018.

 

During the period sales from continuing operations were as follows:

 

6 months to 31 July (unaudited)

2018

2017

% Change

£m

£m

Bulgin

14.3

12.5

14.4%

Checkit

0.4

0.2

144%

EET

1.2

0.9

33.3%

Total

15.9

13.6

16.9%

 

 

Bulgin reported record first half sales during the period with order intake remaining at record levels, substantially ahead of prior year.

 

Checkit revenue more than doubled over the prior year due to the planned installations from new contracts won during the past 12 months.

 

Elektron Eye Technology sales are significantly ahead of the prior year, benefitting from a much improved distribution channel and the pulling forward of scheduled orders by a large distributor.

 

The Group traded ahead of market expectations in the first half.

 

The Group continued to be cash generative during the period, despite the increased working capital demands to satisfy the strong trading performance. In addition £0.8 million was received during the period in respect of the disposal of Queensgate Nano. Net cash as at 31 July 2018 was £6.8 million (31 July 2017: £2.0 million; 31 January 2018: £5.2 million). 

 

Elektron expects to announce its interim results on 19 September 2018.

 

John Wilson, Chief Executive Officer of Elektron, said:

 

"Strong double digit sales growth during the first half of the year is representative of the multi-year transformation of our business. As a result of strong trading in the first half, and current visibility, we now expect our performance for the full year to be ahead of market expectations."

 

 

For further enquiries:

  

Elektron Technology plc

 

+44 (0) 1223 371 000 

www.elektron-technology.com

 

 

John Wilson (Chief Executive Officer)

 

 

Andy Weatherstone (Chief Financial Officer & Company Secretary)

 

 

 

 

 

N+1 Singer (Nominated Adviser & Broker)

 

+44 (0) 20 7496 3000 

Shaun Dobson / Jen Boorer (Corporate Finance)

 

 

 

 

The information communicated in this announcement is inside information for the purposes of Article 7 of Regulation 596/2014.

 

Notes to Editors

About Elektron Technology:

Elektron conceives designs and markets innovative products and services for businesses that connect, monitor and control. We have a multi skilled team of engineers, software and product line specialists based in Cambridge focused on the opportunities created by global trends in the following areas:

- Demand for ubiquitous power and data: Bulgin

- Real-time operations management using Internet of Things (IoT) technology: Checkit

- Screening for the effects of ageing on sight: Elektron Eye Technology

 

Forward looking statements

This document contains forward looking statements with respect to the business, strategy and plans of Elektron Technology plc and its current goals and expectations relating to its future financial condition and performance. Statements that are not historical facts, including statements about Elektron or management's beliefs and expectations, are forward looking statements. By their nature, forward looking statements involve risk and uncertainty because they relate to events and depend on circumstances that will occur in the future. Elektron's actual future results may differ materially from the results expressed or implied in these forward looking statements as a result of a variety of factors among other things, the economic and business circumstances occurring from time to time in the countries, sectors and business segments in which the Group operates. Key risks and their mitigation have not changed materially in the period from those disclosed on pages 21 to 24 of the annual financial statements for the year ended 31 January 2018. The forward looking statements contained in this document are made as of the date hereof, and Elektron undertakes no obligation to update any of its forward looking statements.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTBRGDICUGBGII
Date   Source Headline
14th Feb 202511:19 amRNSForm 8 (OPD) - Checkit plc
14th Feb 202510:53 amRNSForm 8.3 - Checkit plc
13th Feb 20252:16 pmRNSForm 8.3 - Checkit plc
13th Feb 20251:20 pmRNSForm 8.3 - Checkit Plc
13th Feb 202511:44 amRNSForm 8.5- CHECKIT PLC
12th Feb 20252:34 pmGNWForm 8.3 - Checkit Plc
12th Feb 202511:24 amRNSForm 8.3 - Checkit plc
12th Feb 202510:47 amRNSForm 8.3 - Checkit plc
12th Feb 202510:39 amRNSForm 8.5 (EPT/RI)
11th Feb 202510:51 amEQSForm 8.3 - Checkit PLC
11th Feb 20257:00 amRNSRecommended All-Share Merger with Crimson Tide
20th Jan 20257:00 amRNSContract Renewals and Wins
17th Jan 20259:11 amRNSHolding(s) in Company
4th Dec 20241:18 pmRNSBoard Change
3rd Dec 202412:41 pmRNSHolding(s) in Company
30th Oct 202412:03 pmRNSHolding(s) in Company
30th Oct 202410:19 amRNSHolding(s) in Company
29th Oct 202411:38 amRNSHolding(s) in Company
7th Oct 20247:00 amRNSConfirmation of CFO Appointment
16th Sep 20243:01 pmRNSDirector/PDMR Shareholding
13th Sep 202410:46 amRNSDirector/PDMR Shareholding
12th Sep 20247:00 amRNSInterim Results
4th Sep 20247:00 amRNSNotice of Results and Investor Presentation
30th Jul 20247:00 amRNSBoard changes
10th Jul 20247:00 amRNSSurrender and grant of options and PDMR dealings
2nd Jul 20247:00 amRNSContract Win
27th Jun 20247:00 amRNSSuccessful conclusion of VAT recoverability case
26th Jun 20247:00 amRNSIntention not to make an offer for Crimson Tide
24th Jun 20245:30 pmRNSForm 8.3 - Checkit Plc
24th Jun 202411:59 amRNSForm 8.5 (EPT/RI)
21st Jun 202410:36 amRNSForm 8.5 (EPT/RI)
20th Jun 202410:47 amRNSForm 8.5 (EPT/RI)
20th Jun 202410:46 amRNSForm 8.3 - Checkit plc - Amendment
19th Jun 202411:54 amRNSForm 8.5 (EPT/RI)
18th Jun 20245:31 pmRNSForm 8.3 - Checkit Plc
18th Jun 20244:23 pmRNSForm 8.3 - Checkit Plc
14th Jun 20246:10 pmRNSForm 8.3 - Checkit PLC
14th Jun 202412:14 pmRNSForm 8.3 - Checkit plc
14th Jun 202411:00 amRNSForm 8.5 (EPT/RI)
14th Jun 20249:42 amRNSForm 8.3 - Checkit plc
13th Jun 202411:37 amRNSForm 8.5 (EPT/RI)
12th Jun 20243:22 pmRNSForm 8 (OPD) - Checkit plc
12th Jun 202411:49 amRNSForm 8.5 (EPT/RI)
12th Jun 20249:29 amRNSForm 8.5 (EPT/RI) - Replacement
12th Jun 20249:19 amRNSForm 8.3 - Checkit plc
12th Jun 20247:00 amRNSContract Wins
11th Jun 20246:15 pmRNSForm 8.3 - Checkit plc - Amendment
11th Jun 20246:14 pmRNSForm 8.3 - Crimson Tide plc - Amendment
11th Jun 202412:04 pmRNSForm 8.5 (EPT/RI)
10th Jun 202412:43 pmEQSForm 8.3 - Apex Fundrock Limited : Form 8.3 - OPD - Checkit PLC

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.